Our research team has been closely tracking the $INJ blockchain! 🧐 We’ve observed rapid growth on both data and institutional partnership fronts, achieving impressive results across the board! 📊 On the data front: Revenue/FDV stands at 0.95, surpassing major blockchains like SOL and SUI, making it one of the most undervalued chains today! 📝 On institutional partnerships: Recently, Injective partnered with GULF Group, a Thai energy giant with a $27B market cap and extensive holdings in energy, telecommunications, banking, and more. Their subsidiary, Gulf Labs, has become an institutional validator node for Injective—and plans are already underway to co-develop RWA tokenization, stablecoins, and even provide AI computing and data center resources to on-chain developers in Thailand! This isn’t an isolated move. Injective’s recent institutional initiatives have been increasingly bold: · Korean powerhouse collaboration: POSCO, Korea’s largest trading company, and LG CNS have launched a real-world trade receivables tokenization pilot on Injective. · Institutional compliance fund: M-INJ, Asia’s first INJ fund regulated by Thailand’s SEC, has officially launched. · Traditional finance migration: Pineapple Financial has migrated over $1 billion in mortgage records directly onto Injective. · Regulatory milestone: Injective has obtained registered transfer agent status from the U.S. SEC. In summary, as an established blockchain, Injective has been delivering a series of major moves—truly a case of long-term preparation paying off. Since releasing its updated whitepaper, its institutional adoption and compliance progress have accelerated dramatically. More high-impact partnerships are expected to roll out across Asia and globally. Injective is rapidly positioning itself to capture the trillion-dollar institutional on-chain finance market—stay tuned! 🧐